$5.890
-0.137 (-2.32%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de SPRY por análisis de gráficos similares
Alphio's SPRY stock price prediction model matches the current ARS Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.88 (-0.20%). The 1-week path is $5.99 (+1.66%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de ARS Pharmaceuticals Inc?
ARS Pharmaceuticals Inc is currently trading at $5.89, significantly below analyst price targets of $25 and $30, indicating potential upside. However, the company has a troubling net income of -$62.34 million for Q2 2026 and faces class action lawsuits, which pose risks. The RSI is at 51.14, suggesting the stock is neither overbought nor oversold, but the recent 23% drop due to insurance coverage issues raises concerns about market confidence. Therefore, while there is potential for growth, the risks are substantial, warranting a hold position for now.
SPRY cerró en $5.89 el Friday, tras bajar -2.32%
ARS Pharmaceuticals Inc (SPRY) last closed at $5.89, losing -2.32%. These facts feed the 1-day and 1-week SPRY price prediction above.
Factores de la previsión
Los factores de la previsión de ARS Pharmaceuticals Inc (SPRY) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de SPRY, ordenadas por similitud.
Análisis de estacionalidad de SPRY
Historically the probability of a positive August return for SPRY is 68.25%. May offers the highest probability of a positive month at 68.25%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de SPRY
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $29.36 | $32.52 | $49.58 | +452.05% |
| Sep 2026 | $31.79 | $32.52 | $32.87 | +452.05% |
| Oct 2026 | $44.41 | $48.27 | $49.95 | +719.50% |
| Nov 2026 | $21.36 | $33.41 | $45.12 | +467.20% |
| Dec 2026 | $33.53 | $48.27 | $57.15 | +719.50% |
En 2026, se proyecta que ARS Pharmaceuticals Inc (SPRY) oscile entre $21.36 y $57.15.
Previsión mensual de ARS Pharmaceuticals Inc para 2026
En Aug de 2026, se proyecta que ARS Pharmaceuticals Inc promedie $32.52, con un mínimo de $29.36 y un máximo de $49.58.
En Sep de 2026, se proyecta que ARS Pharmaceuticals Inc promedie $32.52, con un mínimo de $31.79 y un máximo de $32.87.
En Oct de 2026, se proyecta que ARS Pharmaceuticals Inc promedie $48.27, con un mínimo de $44.41 y un máximo de $49.95.
En Nov de 2026, se proyecta que ARS Pharmaceuticals Inc promedie $33.41, con un mínimo de $21.36 y un máximo de $45.12.
En Dec de 2026, se proyecta que ARS Pharmaceuticals Inc promedie $48.27, con un mínimo de $33.53 y un máximo de $57.15.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.